Gilead Sciences, Inc. News Headlines

Get GILD Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Filtered By
Ordered By

Cohen’s Point72 Asset Management buys a stake in MacroGenics
4/18/2014 9:00:00 AM - Market Realist

Has A Streamlined FDA Raised The Value Of Drug Stocks?
4/17/2014 5:33:00 PM - Investor's Business Daily

After Shaky Start, Weibo Jumps in Nasdaq Debut
4/17/2014 4:00:00 PM - Fox Business

After Shaky Start, Weibo Jumps in Nasdaq Debut
4/17/2014 12:15:00 PM - Fox Business

Noteworthy ETF Outflows: VHT, GILD, MDT, ESRX
4/17/2014 10:50:34 AM - BNK Invest

China's Weibo Set to Debut After Cutting IPO Size
4/17/2014 10:15:00 AM - Fox Business

Ready For A Rebound? Gilead's $1000 Pill
4/17/2014 7:38:00 AM - Seeking Alpha

Rolling The Dice With Earnings
4/16/2014 5:29:00 PM - Seeking Alpha

Gilead Sciences May See A Healthy Earnings Beat
4/16/2014 1:35:00 PM - Seeking Alpha

Gilead: This Baby Has Been Thrown Away With The Bathwater
4/16/2014 8:50:00 AM - Seeking Alpha

Bristol-Myers Seeks Approval for HIV Combo Drug - Analyst Blog
4/15/2014 6:30:01 PM -

Sales of Johnson's New Hepatitis Drug Soars
4/15/2014 1:15:00 PM - Dow Jones Business News

Sales of Johnson & Johnson's New Hepatitis Drug Soars
4/15/2014 12:55:00 PM - Dow Jones Business News

Sales of Johnson s New Hepatitis Drug Soars
4/15/2014 12:55:00 PM - Dow Jones Business News

S&P 500 Movers: NEM, TRIP
4/15/2014 11:43:56 AM - BNK Invest

Hard-to-Cure Patients May Benefit from Merck's HCV Drug - Analyst Blog
4/14/2014 5:10:01 PM -

Positive Data on AbbVie's HCV Program - Analyst Blog
4/14/2014 4:50:01 PM -

Gilead Sciences' Solvadi Is A Game Changer
4/14/2014 4:26:00 PM - Seeking Alpha

Markets Falling? Get Your Defense Ready
4/14/2014 2:47:00 PM - Investopedia

Gilead Bucks Biotech Trend Thanks to Sovaldi News - Analyst Blog
4/14/2014 11:30:01 AM -

Investment Implications Of The Trash Crash: Don't Panic, Don't Kid Yourself, Be Disciplined
4/14/2014 10:34:00 AM - Seeking Alpha

Pre-Market Most Active for Apr 14, 2014 : C, ING, BAC, FB, QQQ, ALU, TVIX, BCS, NBG, XIV, ASML, GILD
4/14/2014 8:39:56 AM - News

Reevaluating Gilead Sciences After The Sell-Off
4/14/2014 8:38:00 AM - Seeking Alpha

Bristol-Myers Submits NDA For Combination Tablet Of Atazanavir With Cobicistat
4/14/2014 8:14:00 AM - RTT News

Encouraging Results on Gilead's Sovaldi - Analyst Blog
4/11/2014 5:15:01 PM -